在治疗多发性骨髓瘤的双特异性抗体
Xiang Zhou1, Xianghui Xiao1, Klaus Martin Kortuem1
1Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
Hematology/oncology clinics of North America
|January 10, 2024
概括
新型免疫疗法,如仿真抗原受体 (CAR) -T细胞和双特异性抗体 (bsAbs),正在改变多发性骨髓瘤 (MM) 治疗. 针对B细胞成熟抗原的向显示出在复发性/耐药性MM的有希望的疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
背景情况:
- 多发性骨髓瘤 (MM) 治疗领域正在迅速发展.
- 基于T细胞的免疫疗法代表了复发性/耐药性MM的显著发展.
- 化学抗原受体 (CAR) -T细胞和双特异性抗体 (bsAbs) 是关键的新选择.
研究的目的:
- 审查MM中新型免疫疗法的出现和有效性.
- 突出B细胞成熟抗原作为CAR T细胞和bsAb疗法的首要目标.
- 评估bsAbs在复发性/耐药性MM (RRMM) 的安全性和有效性.
主要方法:
- 审查最近的临床试验数据.
- 专注于基于T细胞的免疫疗法.
- 针对B细胞成熟抗原的治疗方法的分析.
主要成果:
- 卡尔T细胞和bsAbs在MM中表现出高效率.
- 对于这些疗法,B细胞成熟抗原是主要的向抗原.
- 临床试验表明bsAbs在RRMM中具有有希望的疗效和可接受的安全性.
结论:
- 新型免疫疗法,特别是针对B细胞成熟抗原的bsAbs,为RRMM提供了有效的治疗策略.
- bsAbs的安全性和疗效概况支持它们在MM治疗中的作用.
- 对基于T细胞的治疗方法的持续研究对于不断发展的MM护理至关重要.
相关概念视频
01:31Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K